nodes	percent_of_prediction	percent_of_DWPC	metapath
Promazine—Chloropyramine—Rosiglitazone—type 2 diabetes mellitus	0.142	0.646	CrCrCtD
Promazine—ADRA2A—type 2 diabetes mellitus	0.102	0.325	CbGaD
Promazine—HTR2C—type 2 diabetes mellitus	0.0941	0.299	CbGaD
Promazine—Tripelennamine—Rosiglitazone—type 2 diabetes mellitus	0.0776	0.354	CrCrCtD
Promazine—CYP1A2—type 2 diabetes mellitus	0.071	0.226	CbGaD
Promazine—CYP3A4—type 2 diabetes mellitus	0.047	0.15	CbGaD
Promazine—DRD4—Bromocriptine—type 2 diabetes mellitus	0.0309	0.0818	CbGbCtD
Promazine—ADRA1D—Bromocriptine—type 2 diabetes mellitus	0.0244	0.0645	CbGbCtD
Promazine—DRD1—Bromocriptine—type 2 diabetes mellitus	0.0221	0.0586	CbGbCtD
Promazine—ADRA1B—Bromocriptine—type 2 diabetes mellitus	0.0177	0.047	CbGbCtD
Promazine—HTR2C—Bromocriptine—type 2 diabetes mellitus	0.0162	0.0429	CbGbCtD
Promazine—HTR2A—Bromocriptine—type 2 diabetes mellitus	0.0146	0.0387	CbGbCtD
Promazine—ADRA2A—Bromocriptine—type 2 diabetes mellitus	0.0146	0.0387	CbGbCtD
Promazine—ADRA1A—Bromocriptine—type 2 diabetes mellitus	0.014	0.0371	CbGbCtD
Promazine—DRD2—Bromocriptine—type 2 diabetes mellitus	0.0134	0.0356	CbGbCtD
Promazine—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0109	0.0289	CbGbCtD
Promazine—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0107	0.0283	CbGbCtD
Promazine—CYP2C9—Glipizide—type 2 diabetes mellitus	0.00977	0.0259	CbGbCtD
Promazine—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.00929	0.0246	CbGbCtD
Promazine—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.00929	0.0246	CbGbCtD
Promazine—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.00909	0.0241	CbGbCtD
Promazine—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.00858	0.0227	CbGbCtD
Promazine—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.00828	0.0219	CbGbCtD
Promazine—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.00791	0.021	CbGbCtD
Promazine—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.00773	0.0205	CbGbCtD
Promazine—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.00773	0.0205	CbGbCtD
Promazine—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.00713	0.0189	CbGbCtD
Promazine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00697	0.0185	CbGbCtD
Promazine—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.00689	0.0182	CbGbCtD
Promazine—CYP2C9—Valsartan—type 2 diabetes mellitus	0.0063	0.0167	CbGbCtD
Promazine—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.00623	0.0165	CbGbCtD
Promazine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00621	0.0165	CbGbCtD
Promazine—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.00589	0.0156	CbGbCtD
Promazine—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00585	0.0155	CbGbCtD
Promazine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00568	0.0151	CbGbCtD
Promazine—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00561	0.0149	CbGbCtD
Promazine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00497	0.0132	CbGbCtD
Promazine—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00476	0.0126	CbGbCtD
Promazine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00449	0.0119	CbGbCtD
Promazine—CYP2C19—Losartan—type 2 diabetes mellitus	0.00435	0.0115	CbGbCtD
Promazine—CYP1A2—Losartan—type 2 diabetes mellitus	0.00401	0.0106	CbGbCtD
Promazine—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00395	0.0105	CbGbCtD
Promazine—CYP2C9—Losartan—type 2 diabetes mellitus	0.00362	0.00958	CbGbCtD
Promazine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0034	0.00902	CbGbCtD
Promazine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00326	0.00864	CbGbCtD
Promazine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00326	0.00864	CbGbCtD
Promazine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00309	0.00817	CbGbCtD
Promazine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0023	0.00609	CbGbCtD
Promazine—CYP3A4—Losartan—type 2 diabetes mellitus	0.0021	0.00557	CbGbCtD
Promazine—HTR2A—arteriole—type 2 diabetes mellitus	0.00139	0.136	CbGeAlD
Promazine—HTR2A—sympathetic nervous system—type 2 diabetes mellitus	0.000883	0.0864	CbGeAlD
Promazine—DRD1—nerve—type 2 diabetes mellitus	0.000856	0.0839	CbGeAlD
Promazine—HTR2A—autonomic nervous system—type 2 diabetes mellitus	0.000593	0.0581	CbGeAlD
Promazine—HTR2A—hindlimb—type 2 diabetes mellitus	0.000549	0.0537	CbGeAlD
Promazine—DRD2—nerve—type 2 diabetes mellitus	0.000506	0.0495	CbGeAlD
Promazine—ADRA2A—peripheral nervous system—type 2 diabetes mellitus	0.000503	0.0493	CbGeAlD
Promazine—HTR2A—peripheral nervous system—type 2 diabetes mellitus	0.000428	0.0419	CbGeAlD
Promazine—HTR2A—artery—type 2 diabetes mellitus	0.000336	0.0329	CbGeAlD
Promazine—HTR2A—nerve—type 2 diabetes mellitus	0.000334	0.0327	CbGeAlD
Promazine—ADRA1B—kidney—type 2 diabetes mellitus	0.000315	0.0308	CbGeAlD
Promazine—HTR2A—endothelium—type 2 diabetes mellitus	0.000284	0.0278	CbGeAlD
Promazine—CHRM2—cardiovascular system—type 2 diabetes mellitus	0.000242	0.0237	CbGeAlD
Promazine—CHRM1—cardiovascular system—type 2 diabetes mellitus	0.00022	0.0216	CbGeAlD
Promazine—DRD2—retina—type 2 diabetes mellitus	0.00021	0.0205	CbGeAlD
Promazine—CHRM3—kidney—type 2 diabetes mellitus	0.000193	0.0189	CbGeAlD
Promazine—ADRA2A—islet of Langerhans—type 2 diabetes mellitus	0.00019	0.0186	CbGeAlD
Promazine—ADRA1A—cardiovascular system—type 2 diabetes mellitus	0.000181	0.0177	CbGeAlD
Promazine—CHRM3—adipose tissue—type 2 diabetes mellitus	0.000174	0.017	CbGeAlD
Promazine—ADRA1A—adipose tissue—type 2 diabetes mellitus	0.000159	0.0156	CbGeAlD
Promazine—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.000142	0.0139	CbGeAlD
Promazine—HTR2A—retina—type 2 diabetes mellitus	0.000138	0.0135	CbGeAlD
Promazine—ADRA2A—pancreas—type 2 diabetes mellitus	0.000134	0.0131	CbGeAlD
Promazine—ADRA2A—cortex of kidney—type 2 diabetes mellitus	0.000131	0.0128	CbGeAlD
Promazine—HRH1—adipose tissue—type 2 diabetes mellitus	0.000123	0.0121	CbGeAlD
Promazine—ADRA2A—adipose tissue—type 2 diabetes mellitus	0.000121	0.0119	CbGeAlD
Promazine—HTR2A—cardiovascular system—type 2 diabetes mellitus	0.000117	0.0114	CbGeAlD
Promazine—HTR2A—kidney—type 2 diabetes mellitus	0.000114	0.0112	CbGeAlD
Promazine—Captodiame—HTR2C—type 2 diabetes mellitus	0.000113	0.0354	CrCbGaD
Promazine—CYP2C19—liver—type 2 diabetes mellitus	0.000113	0.0111	CbGeAlD
Promazine—ADRA1A—liver—type 2 diabetes mellitus	0.000112	0.0109	CbGeAlD
Promazine—CYP3A4—kidney—type 2 diabetes mellitus	0.000106	0.0104	CbGeAlD
Promazine—Fluphenazine—CALM1—type 2 diabetes mellitus	0.000101	0.0314	CrCbGaD
Promazine—CYP1A2—liver—type 2 diabetes mellitus	9.25e-05	0.00905	CbGeAlD
Promazine—CYP2C9—liver—type 2 diabetes mellitus	8.78e-05	0.00859	CbGeAlD
Promazine—Propericiazine—ADRA2A—type 2 diabetes mellitus	8.54e-05	0.0266	CrCbGaD
Promazine—Promethazine—CALM1—type 2 diabetes mellitus	8.17e-05	0.0254	CrCbGaD
Promazine—Trifluoperazine—CALM1—type 2 diabetes mellitus	8.06e-05	0.0251	CrCbGaD
Promazine—Perphenazine—CALM1—type 2 diabetes mellitus	7.97e-05	0.0248	CrCbGaD
Promazine—Cyamemazine—HTR2C—type 2 diabetes mellitus	7.87e-05	0.0245	CrCbGaD
Promazine—Metixene—HTR2C—type 2 diabetes mellitus	7.31e-05	0.0228	CrCbGaD
Promazine—HTR2A—liver—type 2 diabetes mellitus	7.23e-05	0.00708	CbGeAlD
Promazine—CYP3A4—liver—type 2 diabetes mellitus	6.69e-05	0.00655	CbGeAlD
Promazine—Chlorpromazine—CALM1—type 2 diabetes mellitus	6.32e-05	0.0197	CrCbGaD
Promazine—Cyclobenzaprine—CYP1A2—type 2 diabetes mellitus	5.52e-05	0.0172	CrCbGaD
Promazine—Carbamazepine—ABCC2—type 2 diabetes mellitus	5.15e-05	0.0161	CrCbGaD
Promazine—Mesoridazine—HTR2C—type 2 diabetes mellitus	4.8e-05	0.0149	CrCbGaD
Promazine—Benzphetamine—ADRA2A—type 2 diabetes mellitus	4.7e-05	0.0147	CrCbGaD
Promazine—Prochlorperazine—HTR2C—type 2 diabetes mellitus	4.64e-05	0.0145	CrCbGaD
Promazine—Fluphenazine—ADRA2A—type 2 diabetes mellitus	4.56e-05	0.0142	CrCbGaD
Promazine—Fluphenazine—HTR2C—type 2 diabetes mellitus	4.2e-05	0.0131	CrCbGaD
Promazine—Clomipramine—ADRA2A—type 2 diabetes mellitus	4.17e-05	0.013	CrCbGaD
Promazine—Brompheniramine—CYP2E1—type 2 diabetes mellitus	4.13e-05	0.0129	CrCbGaD
Promazine—Propiomazine—HTR2C—type 2 diabetes mellitus	4.04e-05	0.0126	CrCbGaD
Promazine—Alimemazine—CYP3A4—type 2 diabetes mellitus	3.96e-05	0.0124	CrCbGaD
Promazine—Thioridazine—ADRA2A—type 2 diabetes mellitus	3.93e-05	0.0122	CrCbGaD
Promazine—Clomipramine—HTR2C—type 2 diabetes mellitus	3.84e-05	0.012	CrCbGaD
Promazine—Trimipramine—ADRA2A—type 2 diabetes mellitus	3.84e-05	0.012	CrCbGaD
Promazine—Chlorprothixene—HTR2C—type 2 diabetes mellitus	3.82e-05	0.0119	CrCbGaD
Promazine—Tamoxifen—ABCC2—type 2 diabetes mellitus	3.82e-05	0.0119	CrCbGaD
Promazine—Methotrimeprazine—ADRA2A—type 2 diabetes mellitus	3.75e-05	0.0117	CrCbGaD
Promazine—Pipotiazine—CYP1A2—type 2 diabetes mellitus	3.67e-05	0.0114	CrCbGaD
Promazine—Doxepin—ADRA2A—type 2 diabetes mellitus	3.66e-05	0.0114	CrCbGaD
Promazine—Cyclobenzaprine—CYP3A4—type 2 diabetes mellitus	3.65e-05	0.0114	CrCbGaD
Promazine—Thioridazine—HTR2C—type 2 diabetes mellitus	3.62e-05	0.0113	CrCbGaD
Promazine—Perphenazine—ADRA2A—type 2 diabetes mellitus	3.61e-05	0.0112	CrCbGaD
Promazine—Quetiapine—ADRA2A—type 2 diabetes mellitus	3.54e-05	0.011	CrCbGaD
Promazine—Trimipramine—HTR2C—type 2 diabetes mellitus	3.53e-05	0.011	CrCbGaD
Promazine—Methotrimeprazine—HTR2C—type 2 diabetes mellitus	3.45e-05	0.0108	CrCbGaD
Promazine—Carbamazepine—CYP1A2—type 2 diabetes mellitus	3.44e-05	0.0107	CrCbGaD
Promazine—Mequitazine—CYP3A4—type 2 diabetes mellitus	3.41e-05	0.0106	CrCbGaD
Promazine—Doxepin—HTR2C—type 2 diabetes mellitus	3.37e-05	0.0105	CrCbGaD
Promazine—Trifluoperazine—HTR2C—type 2 diabetes mellitus	3.36e-05	0.0105	CrCbGaD
Promazine—Oxcarbazepine—CYP3A4—type 2 diabetes mellitus	3.34e-05	0.0104	CrCbGaD
Promazine—Fluphenazine—CYP2E1—type 2 diabetes mellitus	3.33e-05	0.0104	CrCbGaD
Promazine—Perphenazine—HTR2C—type 2 diabetes mellitus	3.32e-05	0.0103	CrCbGaD
Promazine—Quetiapine—HTR2C—type 2 diabetes mellitus	3.26e-05	0.0101	CrCbGaD
Promazine—Fluphenazine—CYP1A2—type 2 diabetes mellitus	3.17e-05	0.00987	CrCbGaD
Promazine—Desipramine—HTR2C—type 2 diabetes mellitus	3.09e-05	0.00963	CrCbGaD
Promazine—Diltiazem—CYP3A4—type 2 diabetes mellitus	3.06e-05	0.00954	CrCbGaD
Promazine—Oxcarbazepine—ALB—type 2 diabetes mellitus	2.91e-05	0.00908	CrCbGaD
Promazine—Clomipramine—CYP1A2—type 2 diabetes mellitus	2.9e-05	0.00903	CrCbGaD
Promazine—Thioridazine—CYP2E1—type 2 diabetes mellitus	2.87e-05	0.00894	CrCbGaD
Promazine—Chlorpromazine—ADRA2A—type 2 diabetes mellitus	2.86e-05	0.00892	CrCbGaD
Promazine—Amitriptyline—ADRA2A—type 2 diabetes mellitus	2.83e-05	0.00882	CrCbGaD
Promazine—Methotrimeprazine—CYP2E1—type 2 diabetes mellitus	2.74e-05	0.00854	CrCbGaD
Promazine—Thioridazine—CYP1A2—type 2 diabetes mellitus	2.73e-05	0.00851	CrCbGaD
Promazine—Tamoxifen—CYP2E1—type 2 diabetes mellitus	2.68e-05	0.00835	CrCbGaD
Promazine—Chlorpromazine—HTR2C—type 2 diabetes mellitus	2.63e-05	0.00821	CrCbGaD
Promazine—Imipramine—HTR2C—type 2 diabetes mellitus	2.62e-05	0.00817	CrCbGaD
Promazine—Diphenhydramine—CYP1A2—type 2 diabetes mellitus	2.62e-05	0.00816	CrCbGaD
Promazine—Methotrimeprazine—CYP1A2—type 2 diabetes mellitus	2.61e-05	0.00812	CrCbGaD
Promazine—Amitriptyline—HTR2C—type 2 diabetes mellitus	2.61e-05	0.00812	CrCbGaD
Promazine—Orphenadrine—CYP2E1—type 2 diabetes mellitus	2.6e-05	0.00811	CrCbGaD
Promazine—Brompheniramine—CYP3A4—type 2 diabetes mellitus	2.6e-05	0.00811	CrCbGaD
Promazine—Chlorphenamine—CYP3A4—type 2 diabetes mellitus	2.55e-05	0.00796	CrCbGaD
Promazine—Tamoxifen—CYP1A2—type 2 diabetes mellitus	2.55e-05	0.00794	CrCbGaD
Promazine—Doxepin—CYP1A2—type 2 diabetes mellitus	2.54e-05	0.00792	CrCbGaD
Promazine—Trifluoperazine—CYP1A2—type 2 diabetes mellitus	2.53e-05	0.00789	CrCbGaD
Promazine—Perphenazine—CYP1A2—type 2 diabetes mellitus	2.51e-05	0.00781	CrCbGaD
Promazine—Desipramine—CYP2E1—type 2 diabetes mellitus	2.45e-05	0.00764	CrCbGaD
Promazine—Pipotiazine—CYP3A4—type 2 diabetes mellitus	2.43e-05	0.00756	CrCbGaD
Promazine—Desipramine—CYP1A2—type 2 diabetes mellitus	2.33e-05	0.00727	CrCbGaD
Promazine—Prochlorperazine—CYP3A4—type 2 diabetes mellitus	2.32e-05	0.00723	CrCbGaD
Promazine—Carbamazepine—CYP3A4—type 2 diabetes mellitus	2.28e-05	0.00709	CrCbGaD
Promazine—Acepromazine—ALB—type 2 diabetes mellitus	2.2e-05	0.00686	CrCbGaD
Promazine—Benzphetamine—CYP3A4—type 2 diabetes mellitus	2.16e-05	0.00674	CrCbGaD
Promazine—Thioproperazine—ALB—type 2 diabetes mellitus	2.15e-05	0.00671	CrCbGaD
Promazine—Pipotiazine—ALB—type 2 diabetes mellitus	2.12e-05	0.0066	CrCbGaD
Promazine—Chlorpromazine—CYP2E1—type 2 diabetes mellitus	2.09e-05	0.00651	CrCbGaD
Promazine—Imipramine—CYP2E1—type 2 diabetes mellitus	2.08e-05	0.00648	CrCbGaD
Promazine—Amitriptyline—CYP2E1—type 2 diabetes mellitus	2.07e-05	0.00644	CrCbGaD
Promazine—Chlorpromazine—CYP1A2—type 2 diabetes mellitus	1.99e-05	0.00619	CrCbGaD
Promazine—Imipramine—CYP1A2—type 2 diabetes mellitus	1.98e-05	0.00616	CrCbGaD
Promazine—Amitriptyline—CYP1A2—type 2 diabetes mellitus	1.97e-05	0.00612	CrCbGaD
Promazine—Clomipramine—CYP3A4—type 2 diabetes mellitus	1.92e-05	0.00598	CrCbGaD
Promazine—Trimipramine—CYP3A4—type 2 diabetes mellitus	1.77e-05	0.0055	CrCbGaD
Promazine—Tamoxifen—CYP3A4—type 2 diabetes mellitus	1.69e-05	0.00526	CrCbGaD
Promazine—Doxepin—CYP3A4—type 2 diabetes mellitus	1.68e-05	0.00524	CrCbGaD
Promazine—Clomipramine—ALB—type 2 diabetes mellitus	1.67e-05	0.00522	CrCbGaD
Promazine—Perphenazine—CYP3A4—type 2 diabetes mellitus	1.66e-05	0.00517	CrCbGaD
Promazine—Orphenadrine—CYP3A4—type 2 diabetes mellitus	1.64e-05	0.00511	CrCbGaD
Promazine—Quetiapine—CYP3A4—type 2 diabetes mellitus	1.63e-05	0.00507	CrCbGaD
Promazine—Desipramine—CYP3A4—type 2 diabetes mellitus	1.54e-05	0.00481	CrCbGaD
Promazine—Chlorpromazine—CYP3A4—type 2 diabetes mellitus	1.32e-05	0.0041	CrCbGaD
Promazine—Imipramine—CYP3A4—type 2 diabetes mellitus	1.31e-05	0.00408	CrCbGaD
Promazine—Amitriptyline—CYP3A4—type 2 diabetes mellitus	1.3e-05	0.00405	CrCbGaD
Promazine—Chlorpromazine—ALB—type 2 diabetes mellitus	1.15e-05	0.00358	CrCbGaD
Promazine—Amitriptyline—ALB—type 2 diabetes mellitus	1.14e-05	0.00354	CrCbGaD
Promazine—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	1.52e-06	2.02e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.52e-06	2.02e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.51e-06	2.01e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.51e-06	2e-05	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.5e-06	2e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	1.5e-06	2e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.5e-06	1.99e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.5e-06	1.99e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	1.49e-06	1.98e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.48e-06	1.97e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.48e-06	1.97e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	1.48e-06	1.96e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.48e-06	1.96e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.48e-06	1.96e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.47e-06	1.96e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.47e-06	1.96e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.47e-06	1.96e-05	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.47e-06	1.95e-05	CbGpPWpGaD
Promazine—ADRA2A—Metabolism—PTGS2—type 2 diabetes mellitus	1.47e-06	1.95e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.47e-06	1.95e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.47e-06	1.95e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	1.47e-06	1.95e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.46e-06	1.94e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.46e-06	1.94e-05	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.46e-06	1.94e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	1.46e-06	1.94e-05	CbGpPWpGaD
Promazine—HTR2C—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.46e-06	1.94e-05	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—SRC—type 2 diabetes mellitus	1.45e-06	1.93e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.45e-06	1.93e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.45e-06	1.93e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	1.45e-06	1.92e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	1.45e-06	1.92e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.45e-06	1.92e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.45e-06	1.92e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.44e-06	1.92e-05	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.44e-06	1.91e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	1.44e-06	1.91e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.43e-06	1.91e-05	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.43e-06	1.9e-05	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.43e-06	1.9e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	1.41e-06	1.88e-05	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.41e-06	1.88e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.41e-06	1.88e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	1.41e-06	1.88e-05	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.41e-06	1.88e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.41e-06	1.87e-05	CbGpPWpGaD
Promazine—ADRA1B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.39e-06	1.85e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	1.39e-06	1.85e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.39e-06	1.85e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	1.39e-06	1.85e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	1.39e-06	1.85e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.39e-06	1.84e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	1.39e-06	1.84e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	1.38e-06	1.84e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.38e-06	1.84e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.38e-06	1.84e-05	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.38e-06	1.83e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—RELA—type 2 diabetes mellitus	1.38e-06	1.83e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	1.38e-06	1.83e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.37e-06	1.82e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	1.37e-06	1.82e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.36e-06	1.81e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.36e-06	1.81e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.36e-06	1.81e-05	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.35e-06	1.8e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.35e-06	1.79e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.34e-06	1.78e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.34e-06	1.78e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	1.34e-06	1.78e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.33e-06	1.76e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	1.32e-06	1.76e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.32e-06	1.76e-05	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.31e-06	1.75e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.31e-06	1.73e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	1.3e-06	1.72e-05	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.3e-06	1.72e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.29e-06	1.72e-05	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.29e-06	1.71e-05	CbGpPWpGaD
Promazine—DRD2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.29e-06	1.71e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.27e-06	1.69e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	1.27e-06	1.69e-05	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.27e-06	1.69e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.27e-06	1.68e-05	CbGpPWpGaD
Promazine—DRD2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.27e-06	1.68e-05	CbGpPWpGaD
Promazine—HTR2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.27e-06	1.68e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.26e-06	1.68e-05	CbGpPWpGaD
Promazine—HRH1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.26e-06	1.68e-05	CbGpPWpGaD
Promazine—CHRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.26e-06	1.67e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—SRC—type 2 diabetes mellitus	1.26e-06	1.67e-05	CbGpPWpGaD
Promazine—CHRM3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.25e-06	1.67e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.25e-06	1.67e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.25e-06	1.66e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	1.25e-06	1.66e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.25e-06	1.66e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.25e-06	1.65e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.24e-06	1.65e-05	CbGpPWpGaD
Promazine—HRH1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.24e-06	1.65e-05	CbGpPWpGaD
Promazine—CHRM2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.24e-06	1.65e-05	CbGpPWpGaD
Promazine—ADRA1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.24e-06	1.65e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.24e-06	1.65e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.23e-06	1.64e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.23e-06	1.64e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.23e-06	1.63e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.23e-06	1.63e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.22e-06	1.62e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.22e-06	1.62e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	1.21e-06	1.6e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	1.21e-06	1.6e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—SRC—type 2 diabetes mellitus	1.2e-06	1.6e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.2e-06	1.6e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.2e-06	1.59e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.2e-06	1.59e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.19e-06	1.58e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.19e-06	1.58e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	1.19e-06	1.58e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	1.19e-06	1.58e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.18e-06	1.57e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	1.18e-06	1.57e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	1.18e-06	1.57e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.18e-06	1.57e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.18e-06	1.57e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.18e-06	1.56e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.17e-06	1.56e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.17e-06	1.56e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.17e-06	1.56e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	1.17e-06	1.55e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.17e-06	1.55e-05	CbGpPWpGaD
Promazine—DRD2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.17e-06	1.55e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.17e-06	1.55e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.16e-06	1.55e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.16e-06	1.54e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.16e-06	1.54e-05	CbGpPWpGaD
Promazine—ADRA2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.15e-06	1.53e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.15e-06	1.53e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.15e-06	1.53e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.15e-06	1.52e-05	CbGpPWpGaD
Promazine—HRH1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.15e-06	1.52e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.14e-06	1.52e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.14e-06	1.52e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.14e-06	1.52e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.14e-06	1.51e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	1.14e-06	1.51e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	1.14e-06	1.51e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.13e-06	1.51e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.13e-06	1.5e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.13e-06	1.49e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.12e-06	1.49e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.11e-06	1.48e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.11e-06	1.47e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.1e-06	1.46e-05	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—IL6—type 2 diabetes mellitus	1.1e-06	1.46e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.09e-06	1.45e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.09e-06	1.45e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.09e-06	1.45e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.09e-06	1.44e-05	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—IL6—type 2 diabetes mellitus	1.09e-06	1.44e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	1.08e-06	1.44e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—SRC—type 2 diabetes mellitus	1.08e-06	1.44e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.08e-06	1.44e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.08e-06	1.43e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.08e-06	1.43e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.07e-06	1.42e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.07e-06	1.42e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.07e-06	1.42e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.07e-06	1.42e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.06e-06	1.41e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.06e-06	1.41e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.06e-06	1.41e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.06e-06	1.41e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.06e-06	1.4e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.05e-06	1.4e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.05e-06	1.39e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.04e-06	1.39e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.04e-06	1.38e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	1.04e-06	1.38e-05	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—IL6—type 2 diabetes mellitus	1.04e-06	1.38e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	1.04e-06	1.38e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	1.04e-06	1.38e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.04e-06	1.38e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	1.03e-06	1.37e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.02e-06	1.36e-05	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.01e-06	1.35e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	1.01e-06	1.34e-05	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—AKT1—type 2 diabetes mellitus	1e-06	1.33e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—SRC—type 2 diabetes mellitus	9.94e-07	1.32e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.92e-07	1.32e-05	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—IL6—type 2 diabetes mellitus	9.9e-07	1.32e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	9.81e-07	1.3e-05	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—IL6—type 2 diabetes mellitus	9.77e-07	1.3e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.76e-07	1.3e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.74e-07	1.29e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.73e-07	1.29e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.71e-07	1.29e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.68e-07	1.29e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.68e-07	1.29e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	9.63e-07	1.28e-05	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.59e-07	1.27e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.59e-07	1.27e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.57e-07	1.27e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.56e-07	1.27e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.55e-07	1.27e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.52e-07	1.26e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	9.49e-07	1.26e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.49e-07	1.26e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.4e-07	1.25e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.37e-07	1.25e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	9.32e-07	1.24e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	9.27e-07	1.23e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	9.17e-07	1.22e-05	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.14e-07	1.21e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	9.14e-07	1.21e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	9.03e-07	1.2e-05	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.01e-07	1.2e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.88e-07	1.18e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	8.87e-07	1.18e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	8.87e-07	1.18e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.71e-07	1.16e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—IL6—type 2 diabetes mellitus	8.47e-07	1.13e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	8.11e-07	1.08e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—IL6—type 2 diabetes mellitus	8.11e-07	1.08e-05	CbGpPWpGaD
Promazine—CHRM3—Metabolism—AKT1—type 2 diabetes mellitus	8.05e-07	1.07e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	7.96e-07	1.06e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.82e-07	1.04e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	7.8e-07	1.04e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.48e-07	9.94e-06	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—IL6—type 2 diabetes mellitus	7.48e-07	9.93e-06	CbGpPWpGaD
Promazine—ADRA2A—Metabolism—AKT1—type 2 diabetes mellitus	7.39e-07	9.81e-06	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—IL6—type 2 diabetes mellitus	7.36e-07	9.77e-06	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—IL6—type 2 diabetes mellitus	7.34e-07	9.75e-06	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	7.32e-07	9.72e-06	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—IL6—type 2 diabetes mellitus	7.29e-07	9.69e-06	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—IL6—type 2 diabetes mellitus	7.22e-07	9.6e-06	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—IL6—type 2 diabetes mellitus	7.2e-07	9.57e-06	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	7.16e-07	9.5e-06	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.9e-07	9.16e-06	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	6.84e-07	9.09e-06	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	6.84e-07	9.09e-06	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.79e-07	9.02e-06	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.77e-07	9e-06	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.75e-07	8.97e-06	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.73e-07	8.94e-06	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—IL6—type 2 diabetes mellitus	6.69e-07	8.89e-06	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.66e-07	8.85e-06	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.65e-07	8.83e-06	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	6.26e-07	8.32e-06	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.18e-07	8.2e-06	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	5.23e-07	6.95e-06	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	4.77e-07	6.34e-06	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	4.08e-07	5.42e-06	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	3.15e-07	4.18e-06	CbGpPWpGaD
